Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» MediciNova
MediciNova
Spotlight – Nash in 2023 and beyond
EP Vantage
Thu, 08/3/23 - 10:03 am
NASH
Boehringer Ingelheim
Zealand Pharma
Akero Therapeutics
Axcella Health
Eli Lilly
Pfizer
Ionis Pharmaceuticals
Cascade
AstraZeneca
Gilead Sciences
Novo Nordisk
Ascletis Pharma
MediciNova
MediciNova's Ibudilast Reduces Retinal Thinning in MS Trial Subjects
BioSpace
Wed, 11/25/20 - 10:38 am
MediciNova
OCT
clinical trials
ibudilast
MS
multiple sclerosis
retinal thinning
MediciNova Announces Presentation of Significant Positive Results from Interim Analysis of the Phase 2 Trial of MN-001 (tipelukast) in NASH / NAFLD
CP Wire
Fri, 04/13/18 - 12:47 pm
MediciNova
NASH
MN-001
tipelukast
MediciNova Announces Presentation of Significant Positive Results from Interim Analysis of the Phase 2 Trial of MN-001 (tipelukast) in NASH / NAFLD
Fri, 04/13/18 - 12:46 pm
MediciNova
NASH
MN-001
tipelukast
FDA Grants Rare Pediatric Disease Designation to MediciNova’s MN-166 (ibudilast) for the Treatment of Krabbe Disease
Yahoo
Mon, 01/18/16 - 08:24 pm
FDA
MediciNova
MN-166
Five Biotech Firms Whose Stock-Promoting Efforts Didn't Pay Off
TheStreet.com
Tue, 12/2/14 - 07:31 pm
MediciNova
Agenus
CytRx
CTI BioPharma
Sunesis
MediciNova Rises on FDA's Nod on MN-166 Study Initiation
Yahoo/Zacks.com
Thu, 08/28/14 - 07:25 pm
FDA
MediciNova
MN-166
Lou Gehrig's disease
amyotrophic lateral sclerosis
MediciNova Announces Positive Interim Results of Phase 2a Study of MN-166 (ibudilast) in Opioid Dependence
Yahoo
Tue, 08/19/14 - 08:13 am
MN-166
MediciNova
opioid addiction
MediciNova Releases Notice of Pendency and Settlement of Class Action
Yahoo/BusinessWire
Sat, 04/24/10 - 01:04 pm
MediciNova
lawsuits
MediciNova Completes Acquisition of Avigen
Yahoo/Global NewsWire
Sat, 12/19/09 - 12:27 pm
Avigen
MediciNova
MediciNova Acquiring Avigen: A Post-Mortem
Seeking Alpha
Tue, 08/25/09 - 08:05 am
MediciNova
Avigen
M&A
MediciNova to acquire Avigen for $1.24 a share
Marketwatch
Fri, 08/21/09 - 07:38 am
MediciNova
Avigen
M&A
Avigen Still a Good Value
Seeking Alpha
Tue, 08/18/09 - 06:28 am
Avigen
Genzyme
MediciNova
Avigen: Proposed Merger with MediciNova Back on the Table
Seeking Alpha
Tue, 07/21/09 - 09:20 am
Avigen
MediciNova
M&A
Alameda's Avigen in sale talks
Bizjournals.com
Fri, 06/26/09 - 10:38 am
Alameda
Avigen
MediciNova
M&A
MediciNova reaches tentative deal to buy Avigen
Marketwatch
Thu, 06/25/09 - 08:52 am
MediciNova
Avigen
buyouts
MediciNova Sends Letter to Avigen Board of Directors
Yahoo
Thu, 03/19/09 - 10:32 pm
MediciNova
Avigen